Bupropion/zonisamide
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Vaccinationist (talk | contribs) at 19:20, 28 October 2015. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:20, 28 October 2015 by Vaccinationist (talk | contribs)
 | |
| Combination of | |
|---|---|
| Bupropion | Norepinephrine-dopamine reuptake inhibitor and nicotinic acetylcholine receptor antagonist |
| Zonisamide | Sulfonamide anticonvulsant |
| Legal status | |
| Legal status |
|
| (verify) | |
Bupropion/zonisamide (planned trade name Empatic) is an experimental drug combination for the treatment of obesity.[1] It is being developed by Orexigen Therapeutics. It is currently at phase II testing.[2][3] The combination consists of two prescription medications approved by the U.S. Food and Drug Administration (FDA) for other ailments.[4] When mixed together and tested along with proper diet and moderate exercise, they produced a substantial weight loss effect higher than the group taking a placebo.
Empatic was called Excalia before its name was changed.[5]
See also
References
- ^ Empatic Shows Long-Term Weight Loss, Improved Quality Of Life Contrave(R) Reduces Rate Of Metabolic Syndrome By Half
- ^ Ioannides-Demos, LL; Piccenna, L; McNeil, JJ (2011). "Pharmacotherapies for obesity: past, current, and future therapies" (PDF). Journal of Obesity. 2011: 179674. doi:10.1155/2011/179674. PMC 3006492. PMID 21197148.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Adan, RAH (February 2013). "Mechanisms underlying current and future anti-obesity drugs". Trends in Neurosciences. 36 (2): 133–140. doi:10.1016/j.tins.2012.12.001. PMID 23312373.
- ^ Orexigen says trial of 2nd obesity drug meets goal
- ^ Empatic Obesity Drug Information and News
| α1 |
| ||||
|---|---|---|---|---|---|
| α2 |
| ||||
| β |
| ||||
| |||||||||||||||||||||||||
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- CS1 maint: unflagged free DOI
- Drugs with non-standard legal status
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs that are a combination of chemicals
- All stub articles